Literature DB >> 21220023

Mechanism mediating oligomeric Aβ clearance by naïve primary microglia.

Cheng-Ning Yang1, Young-Ji Shiao, Feng-Shiun Shie, Bo-Shen Guo, Pei-Hao Chen, Chi-Yuan Cho, Yi-Jen Chen, Fong-Lee Huang, Huey-Jen Tsay.   

Abstract

The accumulation of soluble oligomeric amyloid-β peptide (oAβ) proceeds the formation of senile plaques and contributes to synaptic and memory deficits in Alzheimer's disease (AD). The mechanism of mediating microglial oAβ clearance remains unclear and thought to occur via scavenger receptors (SRs) in microglia. SRs respond to their ligands in a subtype-specific manner. Therefore, we sought to identify the specific subtypes of SRs that mediate oAβ internalization and proteases that degrade oAβ species in naïve primary microglia. The component of oAβ species were characterized by western blot analysis, analytical ultracentrifugation analysis, and atomic force microscopy. The oAβ species remained soluble in the medium and microglial lysates during incubation at 37 °C. SR-A, but not CD36, mediated oAβ internalization in microglia as suggested by the use of subtype-specific neutralizing antibodies and small interfering RNAs (siRNAs). Immunoprecipitation analysis showed that oAβ interacted with SR-A on the plasma membrane. After internalization, over 40% of oAβ vesicles were trafficked toward lysosomes and degraded by cysteine proteases, including cathepsin B. The inhibitors of proteasome, neprilysin, matrix metalloproteinases, and insulin degrading enzyme failed to protect internalized oAβ from degradation. Our study suggests that SR-A and lysosomal cathepsin B are critical in microglial oAβ clearance, providing insight into how microglia are involved in the clearance of oAβ and their roles in the early stages of AD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220023     DOI: 10.1016/j.nbd.2011.01.005

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  52 in total

1.  Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases.

Authors:  Ben A Bahr; Meagan L Wisniewski; David Butler
Journal:  Rejuvenation Res       Date:  2012-04       Impact factor: 4.663

Review 2.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

Review 3.  Microglial Aβ receptors in Alzheimer's disease.

Authors:  Yang Yu; Richard D Ye
Journal:  Cell Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.046

4.  Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.

Authors:  Chao Wang; Binggui Sun; Yungui Zhou; Anders Grubb; Li Gan
Journal:  J Biol Chem       Date:  2012-09-28       Impact factor: 5.157

Review 5.  The evolving biology of microglia in Alzheimer's disease.

Authors:  Tarja M Malm; Taylor R Jay; Gary E Landreth
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

6.  Inhibiting ACAT1/SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Aβ1-42 clearance.

Authors:  Yohei Shibuya; Catherine C Y Chang; Li-Hao Huang; Elena Y Bryleva; Ta-Yuan Chang
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

7.  Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis.

Authors:  Li Zhang; Xiao-Hong Fu; Yong Yu; Ruo-Hong Shui; Chun Li; Hai-Ying Zeng; Yu-Lei Qiao; Li-Yan Ni; Qiang Wang
Journal:  Lab Invest       Date:  2014-11-10       Impact factor: 5.662

8.  RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.

Authors:  Dimitry Ofengeim; Sonia Mazzitelli; Yasushi Ito; Judy Park DeWitt; Lauren Mifflin; Chengyu Zou; Sudeshna Das; Xian Adiconis; Hongbo Chen; Hong Zhu; Michelle A Kelliher; Joshua Z Levin; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-13       Impact factor: 11.205

9.  Loss of P2Y₂ nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's disease.

Authors:  Deepa Ajit; Lucas T Woods; Jean M Camden; Christina N Thebeau; Farid G El-Sayed; Glen W Greeson; Laurie Erb; Michael J Petris; Douglas C Miller; Grace Y Sun; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2013-11-06       Impact factor: 5.590

10.  The role of lysosomal proteinases and estradiol in neurodegeneration induced by beta-amyloid.

Authors:  N L Rendakov; L A Lysenko; Yu V Lyupina; N P Sharova; N B Sel'verova; N N Nemova
Journal:  Dokl Biochem Biophys       Date:  2015-09-03       Impact factor: 0.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.